Skip to main content
Thorne Logo Thorne Logo
  • Overview
    • News
    • Events & Presentations
      • Events
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts

Executive Management

  • Overview
    • News
    • Events & Presentations
      • Events
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts

Executive Management Carousel

Portrait

Paul Jacobson, Chairman and Chief Executive Officer

Paul Jacobson has served as our co-founder, Chief Executive Officer, and on our board of directors since 2010. He has also served as co-founder, Chief Executive Officer and on the board of directors for Company subsidiaries, including Thorne Research Inc., Health Elements, LLC and WellnessFX, Inc. since 2010. In addition, he has served on the board of directors for Tecton Group, LLC since 2020, and from 2017 to 2020, he served on the board of directors for Drawbridge Health, Inc. Prior to joining our company, Mr. Jacobson was on the board of directors for Progenics Pharmaceuticals and a Partner and Co-head of the Liquid Capital Markets Department at Goldman Sachs. He holds an M.B.A. from Washington University in Saint Louis and a B.A. in English and Economics from Vanderbilt University. We believe Mr. Jacobson is qualified to serve on our board of directors due to his extensive history with us and his business experience in investment banking and finance.

Portrait

Thomas McKenna, Chief Operating Officer

Thomas McKenna has served as our Chief Operating Officer and on our board of directors since 2010. Before joining our company, he was the Chief Operating Officer of Diversified Natural Products, Inc. Prior to that, he spent most of his career at Bristol-Myers Squibb in a variety of operational roles. Mr. McKenna holds an M.B.A. in Accounting from the Fox School of Business at Temple University and a B.S. in Finance from Fairfield University. We believe that Mr. McKenna is qualified to serve on our board of directors due to his extensive history with us, finance experience and education.

Portrait

Will McCamy, President

Will McCamy has served as President for Thorne Research, Inc. and on the board of directors for Health Elements, LLC, since 2010, both of which are our subsidiaries. Prior to joining our company, Mr. McCamy served as co-founder and President for Xymogen, Inc. Mr. McCamy has over 26 years of experience in the nutritional sciences industry, specifically focusing on the healthcare professional segment but recently expanding into consumer-driven initiatives and sport performance. Mr. McCamy holds a B.S. in Finance from University of Florida.

Portrait

Michelle Crow, Chief Marketing Officer

Michelle Crow has served as our Chief Marketing Officer since November 2017. She has also served on the board of directors for Akreto, Inc. since October 2020. Prior to becoming our Chief Marketing Officer, she held numerous positions from 2012 to October 2017 at our subsidiary Thorne Research Inc., including Vice President of Marketing, Assistant Vice President of Marketing, Director of Marketing, Manager of Operations, and Marketing Associate. Ms. Crow holds an M.B.A. in Marketing and Strategy from the Leonard N. Stern School of Business at New York University and a B.A. in Philosophy and Spanish from Duke University.

Portrait

Scott Hurth, Chief Technology Officer

Scott Hurth has served as our Chief Technology Officer since 2014. He has also served on the board of directors for Akreto, Inc. since October 2020. Prior to his current roles, he co-founded Greydin, LLC, an information technology consulting firm and has held various positions with Amazon. He holds a B.S. in Computer Science from the University of Wisconsin Eau Claire.

Portrait

Stephen Phipps, Chief Innovation Officer

Stephen Phipps has served as our Chief Innovation Officer since January 2021. Prior to his current role, he held numerous positions from 2015 to 2021 at our subsidiary Thorne Research, Inc., including Chief Innovation Officer, Vice President of Research and Development and Director of Clinical Programs. Mr. Phipps is also a member of the American Association of Naturopathic Physicians and the Naturopathic Academy of Primary Care Physicians, and was a practicing Naturopathic physician before joining our Company. He holds a N.D. in Naturopathic Medicine from Bastyr University, a Ph.D. in Pharmaceutical Sciences from the University of Florida and a B.S. in Botany from the University of Florida.

Portrait

Dr. Nathan Price, Chief Science Officer

Dr. Nathan Price currently serves Chief Science Officer of Thorne HealthTech. Previously, Dr. Nathan Price has served as Co-Chief Executive Officer for Onegevity Health, LLC, from November 2020 until its merger with our Company in March 2021. Dr. Price has also served on the Board of Directors of Health and Environmental Sciences, a non-profit, since 2018. Since 2017, Dr. Price has co-led the Hood-Price Integrated Lab for Systems Biomedicine with biotechnology pioneer Lee Hood. Prior to his current roles, Dr. Price served as co-founder and Director of Arivale Inc. from 2014 to 2019. He has also served on many advisory boards, including Roche (Personalized Healthcare Division), Providence St. Joseph Health, Sera Prognostics, Navican, Basepaws, Trelys and the Novo Nordisk Foundation Center for Biosustainability. Dr. Price holds a Ph.D. in Bioengineering from the University of California, San Diego, an M.S. in Bioengineering from the University of California, San Diego and a B.S. in Chemical Engineering from Brigham Young University.

Portrait

Dr. Bodi Zhang, Chief Strategy Officer

Dr. Bodi Zhang currently serves Chief Strategy Officer of Thorne HealthTech. Previously, Dr. Bodi Zhang has served as Chief Science Officer for Onegevity Health, LLC from January 2018 until its merger with our company in March 2021. Prior to his current role, Dr. Zhang served as Vice President, Corporate and Medical Strategy from January 2015 to 2018, and as General Manager, Strategic Alliance from January 2013 to 2015. Prior to joining our company, Dr. Zhang worked at Deallus Group, a global healthcare consultancy. Prior to the Deallus Group, Dr. Zhang was a Research Assistant Professor of Pharmacology at Tufts University, Boston. As a scientist, Bodi’s research focused on autoimmune diseases and published top-tier research publications, including in Proceedings of the National Academy of Sciences, The Journal of Allergy and Clinical Immunology and Nature Reviews. Dr. Zhang holds a Ph.D in Pharmacology and Biochemistry from Tufts University, Boston, an M.P.H in healthcare management from Harvard University, Boston and a M.D. from Peking University, China.

Portrait

Bryan Conley, Chief Financial Officer

Bryan Conley has served as Chief Financial Officer since March 2022. Prior to joining our company, Mr. Conley served as Vice President of Finance of Gravy Analytics, Inc. from February 2018 through September 2021, and as Controller for Plex Systems, Inc. from January 2016 through December 2017. Prior to serving at Plex Systems, Mr. Conley has held finance leadership roles with Beacon Roofing Supply, Inc, U.S. Silica Holdings, Inc. and Hilton Worldwide, Inc. and began his career with PricewaterhouseCoopers, LLP. Mr. Conley holds a M.S. in Accounting and Information Systems from the University of Kansas.

  • Overview
    • News
    • Events & Presentations
      • Events
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts

Investors

  • Thorne.com

Contact us

  • investors@thorne.com

Follow us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn

Stay informed

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Thorne HealthTech, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Thorne HealthTech to send you the requested Investor Email Alert updates.

* Required

Sign up for the latest on news, events and more

*
Investor Alert Options
*




Unsubscribe

Email Alert Sign Up Confirmation

  • Terms of Use
  • Privacy Policy
© Thorne HealthTech - All rights reserved
Powered By Q4 Inc. 5.74.0.1 (opens in new window)